Logo image of BGRY

BERKSHIRE GREY INC (BGRY) Stock Fundamental Analysis

NASDAQ:BGRY - Nasdaq - US0846561076 - Common Stock - Currency: USD

1.4  -0.01 (-0.71%)

After market: 1.4 0 (0%)

Fundamental Rating

3

BGRY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 129 industry peers in the Machinery industry. While BGRY seems to be doing ok healthwise, there are quite some concerns on its profitability. BGRY is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year BGRY has reported negative net income.
BGRY had a negative operating cash flow in the past year.
BGRY Yearly Net Income VS EBIT VS OCF VS FCFBGRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -50M -100M -150M

1.2 Ratios

The profitability ratios for BGRY are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BGRY Yearly ROA, ROE, ROICBGRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100

1.3 Margins

BGRY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BGRY Yearly Profit, Operating, Gross MarginsBGRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -200 -400 -600

5

2. Health

2.1 Basic Checks

BGRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BGRY has more shares outstanding
There is no outstanding debt for BGRY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BGRY Yearly Shares OutstandingBGRY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 50M 100M 150M 200M
BGRY Yearly Total Debt VS Total AssetsBGRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

BGRY has an Altman-Z score of -5.43. This is a bad value and indicates that BGRY is not financially healthy and even has some risk of bankruptcy.
BGRY's Altman-Z score of -5.43 is on the low side compared to the rest of the industry. BGRY is outperformed by 94.62% of its industry peers.
BGRY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.43
ROIC/WACCN/A
WACC9.31%
BGRY Yearly LT Debt VS Equity VS FCFBGRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 50M -50M 100M -100M

2.3 Liquidity

BGRY has a Current Ratio of 1.78. This is a normal value and indicates that BGRY is financially healthy and should not expect problems in meeting its short term obligations.
BGRY has a Current ratio of 1.78. This is in the lower half of the industry: BGRY underperforms 64.62% of its industry peers.
A Quick Ratio of 1.53 indicates that BGRY should not have too much problems paying its short term obligations.
The Quick ratio of BGRY (1.53) is better than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.53
BGRY Yearly Current Assets VS Current LiabilitesBGRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.32% over the past year.
BGRY shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.28%.
The Revenue has been growing by 102.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)14.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)27.28%
Revenue growth 3Y102.15%
Revenue growth 5YN/A
Sales Q2Q%14.88%

3.2 Future

Based on estimates for the next years, BGRY will show a very strong growth in Earnings Per Share. The EPS will grow by 28.01% on average per year.
The Revenue is expected to grow by 79.38% on average over the next years. This is a very strong growth
EPS Next Y-4.13%
EPS Next 2Y28.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year71%
Revenue Next 2Y79.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BGRY Yearly Revenue VS EstimatesBGRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BGRY Yearly EPS VS EstimatesBGRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BGRY. In the last year negative earnings were reported.
Also next year BGRY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BGRY Price Earnings VS Forward Price EarningsBGRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BGRY Per share dataBGRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as BGRY's earnings are expected to grow with 28.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.01%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BGRY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BERKSHIRE GREY INC

NASDAQ:BGRY (7/19/2023, 8:00:01 PM)

After market: 1.4 0 (0%)

1.4

-0.01 (-0.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-11 2023-05-11/amc
Earnings (Next)08-09 2023-08-09/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners17.25%
Ins Owner Change0%
Market Cap340.69M
Analysts43.33
Price Target2.75 (96.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.59%
Min EPS beat(2)-13.12%
Max EPS beat(2)18.3%
EPS beat(4)3
Avg EPS beat(4)7.66%
Min EPS beat(4)-13.12%
Max EPS beat(4)18.3%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-23.15%
Min Revenue beat(2)-32.94%
Max Revenue beat(2)-13.37%
Revenue beat(4)1
Avg Revenue beat(4)29.24%
Min Revenue beat(4)-32.94%
Max Revenue beat(4)166.58%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-32.43%
EPS NY rev (3m)-32.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.11
P/FCF N/A
P/OCF N/A
P/B 8.51
P/tB 8.51
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.27
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 86.95%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.53
Altman-Z -5.43
F-Score4
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)369.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y-4.13%
EPS Next 2Y28.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.28%
Revenue growth 3Y102.15%
Revenue growth 5YN/A
Sales Q2Q%14.88%
Revenue Next Year71%
Revenue Next 2Y79.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.75%
OCF growth 3YN/A
OCF growth 5YN/A